ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
Bayer
Myeloid Therapeutics
SEED Therapeutics, Inc.
DualityBio Inc.
NextCure, Inc.
Tanabe Pharma America, Inc.
Eli Lilly and Company
Yuhan Corporation
AstraZeneca
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Evopoint Biosciences Inc.